Purchase Order 75N95022P00346

The National Institute on Drug Abuse issued a purchase order to Allucent Government Services (Us) LLC on July 1, 2022, for subject matter expert consulting in drug metabolism and pharmacokinetics, with a ceiling value of $673,995.00. Performance occurs in Houston, Texas. The order carries no set-aside designation and operates on labor-hour pricing through June 30, 2025. SCI reporting shows government-invoiced labor of $11 thousand in FY2022 (40 hours), $80 thousand in FY2023 (289 hours), and...

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health under the Department of Health and Human Services, awarded a $11,250 purchase order to Franklin Adme Consult, LLC on September 18, 2025, for subject matter expert consulting services in Drug Metabolism Pharmacokinetics (DMPK). This total small business set-aside contract is structured as a labor hour engagement with a completion date of September 17, 2026, and will support the NIH Blueprint Neurotherapeutics...

<p>The National Institute on Drug Abuse issued a purchase order to Labcorp Early Development Laboratories Inc. valued at $108,254.16 on July 1, 2023, for completion of pharmacokinetics for the MAD portion of the RR-HNK Phase 1 study under the FY26 UDO initiative. Work is performed in Madison, Wisconsin. The order carries a firm fixed price structure and was not set-aside. Ultimate completion date was June 30, 2025.</p>

The National Institute on Drug Abuse awarded a purchase order to Johnson, Graham, a small business sole proprietorship, for medicinal chemistry consulting services on July 26, 2022, with a ceiling value of $437,670 and ultimate completion date of July 26, 2025. The work is performed in Bethesda, Maryland and supports drug discovery initiatives within the NIH Blueprint Neurotherapeutics Network and the NIH Helping to End Addiction Long-term Initiative. The contract is a labor-hour arrangement...

<p>The National Institute on Drug Abuse issued a purchase order to North David K for $14,400.00 on June 14, 2022, for Institutional Animal Care and Use Committee (IACUC) support services. Work is performed in Indian Head, Maryland. The order carries a firm fixed price and an ultimate completion date of June 13, 2025. This purchase order funded the FY26 UDO Initiative and used no set-aside category.</p>

The National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services, awarded a $16,000 purchase order to Cellx, Inc., a small business, on September 29, 2025, for pharmaceutics formulation, chemistry manufacturing and controls (CMC) consulting services supporting drug discovery and development programs. The contract, which runs through September 28, 2028, provides specialized subject matter expert consultation for small molecules and biologics development, with...

The National Institute on Drug Abuse issued a purchase order to Children's Hospital Medical Center valued at $28,175.00 on July 31, 2018, to administratively de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of these fiscal year funds. Performance occurs at Bethesda, Maryland. The order is firm fixed price with no set-aside designation. Ultimate completion...

The National Institute on Drug Abuse awarded a purchase order to Slusher Barbara for pharmacology consulting services in support of the Blueprint Neurotherapeutics Network (BPN) drug discovery and developmental programs, valued at $49,314.99, with an award date of February 23, 2022. The order carries a Total Small Business set-aside. Work is performed in Kingsville, Maryland. The purchase order covers pharmacology consulting and external oversight committee support for NINDS; pricing is...

This is a firm fixed-price purchase order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Detke Biopharma Consulting LLC, a for-profit limited liability company, for clinical pharmacology consulting services. The contract has a ceiling value of $29,138.12 and a period of performance ending on January 13, 2022. The contract is not associated with a larger vehicle and does not have a set-aside designation. The contract was awarded on January 12, 2017 under the Major...

The National Institute on Drug Abuse awarded a firm fixed-price purchase order to Rashid Adnan (UEI: LMD7VXK1MQV9) on March 6, 2020, with a ceiling value of $26,900. The contract, which was solicited without a set-aside designation, calls for the awardee to study the pathophysiology and develop related research deliverables, with work to be performed in Greenbelt, Maryland. The solicitation was posted on January 31, 2020, with a bid due date of February 14, 2020, and the contract ultimately...